Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover study
Donald L. Gilbert, Tanya K. Murphy, Joseph Jankovic, Cathy L. Budman, Kevin J. Black, Roger M. Kurlan, Keith A. Coffman, James T. McCracken, Jorge Juncos, Jon E. Grant, Richard E. Chipkin
Dive into the research topics of 'Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover study'. Together they form a unique fingerprint.